<DOC>
	<DOCNO>NCT02128750</DOCNO>
	<brief_summary>The primary objective work show quantification muscular microvascularisation evaluate injection contrast agent different chronic critical limb ischemia ( revascularization ) ( heal ischemia ) thus make proof utility evaluation PAD therapeutic .</brief_summary>
	<brief_title>Contrast Enhanced Ultrasound Muscle</brief_title>
	<detailed_description>- Peripheral arterial disease ( PAD ) frequent disease incidence men 32.5°/°° 40 year 71°/°° 50 year . Prevalence disease increase age reach 3.7 % 60 69 year old subject ( Kannel 1970 , 1985 , Bloch 1985 ) . - Critical limb ischemia ( CLI ) ischemia define typical chronic ischemic rest pain ischemic skin lesion either ulcer gangrene two week ( Norgren ) . Incidence 500 - 1000 / 106 / year Europe United state . Critical limb ischemia concern 15 - 20 % patient intermittent claudication ( Eneroth 1992 , Taylor 1989 ) . Development lead limb loss frequency estimate 7 % 5 year 12 % 10 year . Problem crucial patient benefit revascularization . Results single medical treatment uncertain . Development neovascularisation innovate therapeutic ( autolog cell stem graft , intramuscular growth factor injection ) represent excite promise field research . - Peripheral arterial disease evaluation stag base measure rest ankle pressure , diagnosis stenosis obliteration ( duplex , angiography , compute tomography scan magnetic resonance imaging ) measure microcirculatory skin perfusion Tc PO2 . On hand , simple tool measure muscular microvascularisation whereas muscle suffer ischemia way skin nerve . Measures muscular perfusion perform Tc 99 , magnetic resonance imaging use clinical practice . CEUS use routine ass hepatic microvascularisation recently show potentially useful study muscle ( Kramer 2008 , Weber 2007 ) . - Ultrasonic contrast agent intravascular microbubbles use low mechanical index generate harmonic allow real time image ultrasonography . Their use allow study parenchyma enhancement real time , notably liver kidney ; also use practice differentiate benign malign tumor ( Correas 2009 ) . Correlations show muscle enhancement study CEUS histologic data capillary vascularisation ( Weber 2005 ) . More recently author show CEUS may allow differentiate patient PAD stage intermittent claudication patient without PAD ( Duerschmied 2006 ) .Very study study patient CLI . Duerschmied show kinetic data muscle enhancement may reflect collateral circulation develop reaction chronic ischemia . CEUS may use study muscular perfusion way TcPO2 reflect cutaneous vascularisation may become evaluation criterion PAD therapeutic near future . - We propose study muscular perfusion CEUS patient critical limb ischemia eligible revascularization ( PTA bypass ) revascularization . Microbubbles injection lead increase muscle echogenicity two sequence : rapid phase 15-20 injection ( arteriolar filling ) intense second phase ( veinular capillary filling ) ( Duerschmied 2006 ) . These two phase may describe measure acoustic intensity function time particular time peak ( TTP ) , area curve ( AUC ) . Time peak seem reliable criterion ( Duerschmied ) .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Thromboangiitis Obliterans</mesh_term>
	<criteria>Men woman 40 year Patients chronic critical limb ischemia define consensus TASC 2 eligible revascularisation Objective evaluation critical ischemia base ankle pressure &lt; 70 mm Hg toe pressure &lt; 50 mm Hg patient ulcer pressure ankle pressure &lt; 50 mm Hg toe pressure &lt; 30 mm Hg patient rest pain . Patient 's consent sign Patients 18 Pregnant breast feed woman Burger 's disease Contra indication use contrast Hypersensitivity sulfurhexafluorure Unstable coronary heart disease , acute stroke , uncompensated heart failure Right leave shunt Serious pulmonary hypertension ( &gt; 90 mm Hg ) Uncontroled increase blood pressure Acute respiratory distress syndrom Consent refuse Patients leg wound prevent ultrasonography</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>